Early administration of IL-12 suppresses EAE through induction of interferon-γ

Journal of Neuroimmunology

Volumn 156, Issue 1-2, 2004, Pages 123-131

  Gran, Bruno ^a   Chu, Niansheng ^a   Zhang, Guang Xian ^a   Yu, Shuo ^a   Li, Yonghai ^a   Chen, Xiao Han ^b   Kamoun, Malek ^b   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoimmunity; Cytokines; EAE; Rodent; Transgenic Knockout

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; MESSENGER RNA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; GENE EXPRESSION REGULATION; INFLAMMATION; INHIBITION KINETICS; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DRUG ADMINISTRATION SCHEDULE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED C57BL;

EID: 4644256224     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.07.019     Document Type: Article

References (32)

1. S. Aggarwal, N. Ghilardi, M.H. Xie, F.J. de Sauvage, and A.L. Gurney Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J. Biol. Chem. 278 2003 1910 1914
2. B. Becher, B.G. Durell, and R.J. Noelle Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 J. Clin. Invest. 110 2002 493 497
3. B. Becher, B.G. Durell, and R.J. Noelle IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis J. Clin. Invest. 112 2003 1186 1191
4. L.L. Carter, and K.M. Murphy Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells J. Exp. Med. 189 1999 1355 1360
5. S.H. Chan, B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers J. Exp. Med. 173 1991 869 879
6. C.Q. Chu, S. Wittmer, and D.K. Dalton Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis J. Exp. Med. 192 2000 123 128
7. C.S. Constantinescu, M. Wysocka, B. Hilliard, E.S. Ventura, E. Lavi, G. Trinchieri, and A. Rostami Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis J. Immunol. 161 1998 5097 5104
8. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein, and J.D. Sedgwick Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 2003 744 748
9. D.M. Frucht, T. Fukao, C. Bogdan, H. Schindler, J.J. O'Shea, and S. Koyasu IFN-gamma production by antigen-presenting cells: mechanisms emerge Trends Immunol. 22 2001 556 560
10. B. Gran, G.X. Zhang, S. Yu, J. Li, X.H. Chen, E.S. Ventura, M. Kamoun, and A. Rostami IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination J. Immunol. 169 2002 7104 7110
11. E.S. Huseby, D. Liggitt, T. Brabb, B. Schnabel, C. Ohlen, and J. Goverman A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis J. Exp. Med. 194 2001 669 676
12. H. Kitaura, N. Nagata, Y. Fujimura, H. Hotokezaka, N. Yoshida, and K. Nakayama Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction J. Immunol. 169 2002 4732 4738
13. H.K. Koblish, C.A. Hunter, M. Wysocka, G. Trinchieri, and W.M. Lee Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect J. Exp. Med. 188 1998 1603 1610
14. J.P. Leonard, K.E. Waldburger, and S.J. Goldman Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin J. Exp. Med. 181 1995 381 386
15. C. Lock, G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, P. Klonowski, A. Austin, N. Lad, N. Kaminski, S.J. Galli, J.R. Oksenberg, C.S. Raine, R. Heller, and L. Steinman Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Nat. Med. 8 2002 500 508
16. M.J. Loza, and B. Perussia Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production J. Immunol. 169 2002 3061 3068
17. X. Ma, and G. Trinchieri Regulation of interleukin-12 production in antigen-presenting cells Adv. Immunol. 79 2001 55 92
18. C.A. Murphy, C.L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R.A. Kastelein, J.D. Sedgwick, and D.J. Cua Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation J. Exp. Med. 198 2003 1951 1957
19. B. Perussia, and M.J. Loza Linear "2-0-1" lymphocyte development: hypotheses on cellular bases for immunity Trends Immunol. 24 2003 235 241
20. D.S. Robinson, and A. O'Garra Further checkpoints in Th1 development Immunity 16 2002 755 758
21. B.M. Segal, B.K. Dwyer, and E.V. Shevach An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease J. Exp. Med. 187 1998 537 546
22. T. Smith, A.K. Hewson, C.I. Kingsley, J.P. Leonard, and M.L. Cuzner Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat Am. J. Pathol. 150 1997 1909 1917
23. L. Steinman Assessment of animal models for MS and demyelinating disease in the design of rational therapy Neuron 24 1999 511 514
24. T.K. Tarrant, P.B. Silver, J.L. Wahlsten, L.V. Rizzo, C.C. Chan, B. Wiggert, and R.R. Caspi Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis J. Exp. Med. 189 1999 219 230
25. G. Trinchieri, S. Pflanz, and R.A. Kastelein The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses Immunity 19 2003 641 644
26. J.M. Wigginton, E. Gruys, L. Geiselhart, J. Subleski, K.L. Komschlies, J.W. Park, T.A. Wiltrout, K. Nagashima, T.C. Back, and R.H. Wiltrout IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy J. Clin. Invest. 108 2001 51 62
27. D.O. Willenborg, S. Fordham, C.C. Bernard, W.B. Cowden, and I.A. Ramshaw IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis J. Immunol. 157 1996 3223 3227
28. D.O. Willenborg, S.A. Fordham, M.A. Staykova, I.A. Ramshaw, and W.B. Cowden IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide J. Immunol. 163 1999 5278 5286
29. C.Y. Wu, J.R. Kirman, M.J. Rotte, D.F. Davey, S.P. Perfetto, E.G. Rhee, B.L. Freidag, B.J. Hill, D.C. Douek, and R.A. Seder Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo Nat. Immunol. 3 2002 852 858
30. P. Zaccone, P. Hutchings, F. Nicoletti, G. Penna, L. Adorini, and A. Cooke The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease Eur. J. Immunol. 29 1999 1933 1942
31. G.X. Zhang, B. Gran, S. Yu, J. Li, I. Siglienti, X. Chen, M. Kamoun, and A. Rostami Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system J. Immunol. 170 2003 2153 2160
32. G.X. Zhang, S. Yu, B. Gran, J. Li, I. Siglienti, X. Chen, D. Calida, E. Ventura, M. Kamoun, and A. Rostami Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis J. Immunol. 171 2003 4485 4492